DE69221919T2 - Piperidin-Derivate - Google Patents
Piperidin-DerivateInfo
- Publication number
- DE69221919T2 DE69221919T2 DE69221919T DE69221919T DE69221919T2 DE 69221919 T2 DE69221919 T2 DE 69221919T2 DE 69221919 T DE69221919 T DE 69221919T DE 69221919 T DE69221919 T DE 69221919T DE 69221919 T2 DE69221919 T2 DE 69221919T2
- Authority
- DE
- Germany
- Prior art keywords
- piperidine derivatives
- piperidine
- trisubstitutedpiperidinyl
- alkylcarboxylates
- carboxylates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67704291A | 1991-03-29 | 1991-03-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69221919D1 DE69221919D1 (de) | 1997-10-09 |
DE69221919T2 true DE69221919T2 (de) | 1998-01-29 |
Family
ID=24717068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69221919T Expired - Lifetime DE69221919T2 (de) | 1991-03-29 | 1992-03-27 | Piperidin-Derivate |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0506478B1 (de) |
JP (1) | JP3056321B2 (de) |
KR (1) | KR100229117B1 (de) |
CN (1) | CN1041309C (de) |
AT (1) | ATE157653T1 (de) |
AU (1) | AU644051B2 (de) |
BR (1) | BR9201084A (de) |
CY (1) | CY2062B1 (de) |
CZ (1) | CZ284993B6 (de) |
DE (1) | DE69221919T2 (de) |
DK (1) | DK0506478T3 (de) |
ES (1) | ES2106825T3 (de) |
FI (1) | FI104323B1 (de) |
GR (1) | GR3025494T3 (de) |
HK (1) | HK1000441A1 (de) |
HU (2) | HU221316B1 (de) |
IE (1) | IE921003A1 (de) |
IL (1) | IL101382A (de) |
MX (1) | MX9201356A (de) |
NO (1) | NO178398C (de) |
NZ (1) | NZ242117A (de) |
RU (1) | RU2076863C1 (de) |
YU (1) | YU30492A (de) |
ZA (1) | ZA922180B (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10161818A1 (de) * | 2001-12-14 | 2003-06-26 | Gruenenthal Gmbh | Substituierte 1,5-Diaminopentan-3-ol-Verbindungen |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5434171A (en) * | 1993-12-08 | 1995-07-18 | Eli Lilly And Company | Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates |
GB9725114D0 (en) * | 1997-11-28 | 1998-01-28 | Pfizer Ltd | Treatment of pruritus |
GB9810671D0 (en) * | 1998-05-18 | 1998-07-15 | Pfizer Ltd | Anti-pruritic agents |
TWI244481B (en) * | 1998-12-23 | 2005-12-01 | Pfizer | 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
GB9912413D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912417D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912410D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912411D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912415D0 (en) * | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912416D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
US6451806B2 (en) | 1999-09-29 | 2002-09-17 | Adolor Corporation | Methods and compositions involving opioids and antagonists thereof |
US6469030B2 (en) | 1999-11-29 | 2002-10-22 | Adolor Corporation | Methods for the treatment and prevention of ileus |
PT1255547E (pt) * | 2000-02-08 | 2008-11-24 | Euro Celtique Sa | Composições de libertação controlada contendo agonistas e antagonistas opióides |
SI1440059T1 (sl) | 2001-10-22 | 2008-08-31 | Pfizer Prod Inc | Derivati 3-azabiciklo(3.1.0)heksana kot antagonisti opioidnega receptorja |
JP3984281B2 (ja) * | 2003-04-14 | 2007-10-03 | ファイザー・プロダクツ・インク | 3−アザビシクロ〔3,2,1〕オクタン誘導体 |
US6992090B2 (en) * | 2003-06-16 | 2006-01-31 | Adolor Corporation | Substituted piperidine compounds and methods of their use |
BRPI0509732A (pt) * | 2004-04-09 | 2007-09-25 | Chugai Pharmaceutical Co Ltd | pró-fármaco solúvel em água, composição farmacêutica, agente terapêutico, agente antifungo e uso do referido pró-fármaco |
US7700626B2 (en) * | 2004-06-04 | 2010-04-20 | Adolor Corporation | Compositions containing opioid antagonists |
TW200744603A (en) | 2005-08-22 | 2007-12-16 | Chugai Pharmaceutical Co Ltd | Novel anticancer concomitant drug |
CN100383121C (zh) * | 2006-03-07 | 2008-04-23 | 天津泰普药品科技发展有限公司 | 阿韦苄酯化合物及其制备方法和以该化合物制备阿韦莫哌的工艺 |
ATE516021T1 (de) | 2006-04-21 | 2011-07-15 | Dsm Ip Assets Bv | Verwendung von opioid-rezeptor-antagonisten |
CN101838233A (zh) * | 2010-05-27 | 2010-09-22 | 北京万全阳光医学技术有限公司 | 一种阿维莫泮关键中间体的制备方法 |
CN101967118B (zh) * | 2010-10-14 | 2013-01-30 | 成都苑东药业有限公司 | 爱维莫潘的制备方法 |
CN105820106B (zh) * | 2015-01-07 | 2018-11-09 | 上海医药工业研究院 | 爱维莫潘中间体的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3884916A (en) * | 1971-03-30 | 1975-05-20 | Janssen Pharmaceutica Nv | 2,2-Diaryl-4-(4-aryl-4-hydroxy-piperidino)-butyramides |
US4115400A (en) * | 1976-05-27 | 1978-09-19 | Eli Lilly And Company | 1-Azoniabicyclo[3.1.0]hexanes |
EP0287339B1 (de) * | 1987-04-16 | 1994-08-17 | Eli Lilly And Company | Piperidine als Opioid-Antagoniste |
FI97540C (fi) * | 1989-11-06 | 1997-01-10 | Sanofi Sa | Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi |
-
1992
- 1992-03-25 ZA ZA922180A patent/ZA922180B/xx unknown
- 1992-03-25 NZ NZ242117A patent/NZ242117A/en not_active IP Right Cessation
- 1992-03-25 CZ CS92902A patent/CZ284993B6/cs not_active IP Right Cessation
- 1992-03-26 NO NO921182A patent/NO178398C/no not_active IP Right Cessation
- 1992-03-26 MX MX9201356A patent/MX9201356A/es unknown
- 1992-03-26 YU YU30492A patent/YU30492A/sh unknown
- 1992-03-26 HU HU9201013A patent/HU221316B1/hu not_active IP Right Cessation
- 1992-03-26 IL IL101382A patent/IL101382A/xx not_active IP Right Cessation
- 1992-03-27 FI FI921345A patent/FI104323B1/fi not_active IP Right Cessation
- 1992-03-27 JP JP4070790A patent/JP3056321B2/ja not_active Expired - Fee Related
- 1992-03-27 EP EP92302751A patent/EP0506478B1/de not_active Expired - Lifetime
- 1992-03-27 DE DE69221919T patent/DE69221919T2/de not_active Expired - Lifetime
- 1992-03-27 DK DK92302751.0T patent/DK0506478T3/da active
- 1992-03-27 AU AU13880/92A patent/AU644051B2/en not_active Ceased
- 1992-03-27 BR BR929201084A patent/BR9201084A/pt not_active Application Discontinuation
- 1992-03-27 ES ES92302751T patent/ES2106825T3/es not_active Expired - Lifetime
- 1992-03-27 KR KR1019920005104A patent/KR100229117B1/ko not_active IP Right Cessation
- 1992-03-27 AT AT92302751T patent/ATE157653T1/de not_active IP Right Cessation
- 1992-03-27 IE IE100392A patent/IE921003A1/en unknown
- 1992-03-27 RU SU925011276A patent/RU2076863C1/ru active
- 1992-03-28 CN CN92102213A patent/CN1041309C/zh not_active Expired - Fee Related
-
1995
- 1995-06-22 HU HU95P/P00379P patent/HU211622A9/hu unknown
-
1997
- 1997-10-20 HK HK97101955A patent/HK1000441A1/xx not_active IP Right Cessation
- 1997-11-26 GR GR970403143T patent/GR3025494T3/el unknown
-
1998
- 1998-06-12 CY CY9802062A patent/CY2062B1/xx unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10161818A1 (de) * | 2001-12-14 | 2003-06-26 | Gruenenthal Gmbh | Substituierte 1,5-Diaminopentan-3-ol-Verbindungen |
US7569585B2 (en) | 2001-12-14 | 2009-08-04 | Gruenenthal Gmbh | 1, 5-diaminopentan-3-ol compounds and related treatment methods |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE157653T1 (de) | Piperidin-derivate | |
DE69531331D1 (de) | Phenylpiperidinderivate als neurokinin antagonists | |
ATE204262T1 (de) | Benzanilidderivate als 5-ht1d-antagonisten | |
DE69431604D1 (de) | Benzofuranderivate als tachykininantagonisten | |
DE69326160T2 (de) | 4-carboxamidopiperidinderivate, zwischenprodukte und verwendung als neurokinin antagonisten | |
EP1607387A3 (de) | 3,4,4-Trisubstituierte Piperidinderivate und ihre Verwendung als Opioid Antagonisten | |
NO930306L (no) | Nye 1,4-dihydropyridinderivater | |
CA2064373A1 (en) | Piperidine derivatives | |
DE69216260D1 (de) | Piperidinderivate | |
DE58907381D1 (de) | Ungesättigte Derivate von 2,2,6,6-Tetramethylpiperidin. | |
DK382788A (da) | 4-amino-substituerede 1,2-dihydroxy-naphthalen-derivater | |
IT8921380A0 (it) | Composti piperazin piperidinici atti all'impiego come stabilizzanti per materiali organici. | |
KR950700297A (ko) | 5-HT3-수용체 길항제로서의 2,6-메타노-2H-퀴놀리진 유도체(2,6-Methano-2H-quinolizin derivative as 5-HT3-receptor antagonist) | |
MY111366A (en) | Piperdine derivatives. | |
DE69200943T2 (de) | Derivate von Piperidin. | |
FR2617165B1 (fr) | Derives du dimethyl-2, 2 chromannol-3 | |
KR900009587A (ko) | 1, 4-디하이드로피리딘 유도체 | |
ITMI912183A1 (it) | Derivato indolico ad attivita' immunostimolante protratta, e relative composizioni farmaceutiche | |
SI0673928T1 (en) | Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists | |
IT8621841A0 (it) | Derivato di clorpromazina avente migliorata biodisponibilita'. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336 |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |